Edwards Lifesciences (BSP:E1WL34) Cyclically Adjusted FCF per Share: R$2.01 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:E1WL34 Edwards Lifesciences Corp BSP:E1WL34
93 GF Score
Price R$105.71
GF Value R$115.66
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Edwards Lifesciences Cyclically Adjusted FCF per Share?

Edwards Lifesciences BSP:E1WL34 93 Cyclically Adjusted FCF per Share is R$2.01 as of Jun. 2026. GuruFocus rates BSP:E1WL34 with a GF Score™ of 93/100 and a GF Value™ of R$115.66 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Edwards Lifesciences's adjusted free cash flow per share for the three months ended in Jun. 2026 was R$1.297. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is R$2.01 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Edwards Lifesciences's average Cyclically Adjusted FCF Growth Rate was 14.80% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 3.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 8.60% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 14.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Edwards Lifesciences was 26.00% per year. The lowest was 3.50% per year. And the median was 17.10% per year.

As of today (2026-08-17), Edwards Lifesciences's current stock price is R$105.71. Edwards Lifesciences's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was R$2.01. Edwards Lifesciences's Cyclically Adjusted Price-to-FCF of today is 52.59.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Edwards Lifesciences was 113.15. The lowest was 41.98. And the median was 70.27.


Edwards Lifesciences  (BSP:E1WL34) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Edwards Lifesciences's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=105.71/2.01
=52.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Edwards Lifesciences was 113.15. The lowest was 41.98. And the median was 70.27.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Edwards Lifesciences Cyclically Adjusted FCF per Share Related Terms


Edwards Lifesciences Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Edwards Lifesciences's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences Cyclically Adjusted FCF per Share Chart

Edwards Lifesciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.68 1.83 1.78 2.10 2.13

Edwards Lifesciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.93 1.97 2.13 1.99 2.01

BSP:E1WL34 vs BSX, DXCM, GEHC: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Edwards Lifesciences's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's Cyclically Adjusted Price-to-FCF falls into.


BSP:E1WL34
93GF Score
Edwards Lifesciences Corp BSP:E1WL34
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Edwards Lifesciences Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Edwards Lifesciences's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.297/333.9520*333.9520
=1.297

Current CPI (Jun. 2026) = 333.9520.

Edwards Lifesciences Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.196 241.428 0.271
201612 0.177 241.432 0.245
201703 0.132 243.801 0.181
201706 0.173 244.955 0.236
201709 0.332 246.819 0.449
201712 0.388 246.524 0.526
201803 0.134 249.554 0.179
201806 0.128 251.989 0.170
201809 0.413 252.439 0.546
201812 0.359 251.233 0.477
201903 -0.087 254.202 -0.114
201906 0.408 256.143 0.532
201909 0.585 256.759 0.761
201912 0.533 256.974 0.693
202003 0.240 258.115 0.311
202006 0.257 257.797 0.333
202009 0.241 260.280 0.309
202012 0.574 260.474 0.736
202103 0.434 264.877 0.547
202106 0.912 271.696 1.121
202109 0.984 274.310 1.198
202112 0.626 278.802 0.750
202203 0.436 287.504 0.506
202206 0.582 296.311 0.656
202209 0.525 296.808 0.591
202212 0.412 296.797 0.464
202303 0.511 301.836 0.565
202306 -0.029 305.109 -0.032
202309 0.722 307.789 0.783
202312 0.097 306.746 0.106
202403 -0.286 312.332 -0.306
202406 0.637 314.175 0.677
202409 0.682 315.301 0.722
202412 -0.470 315.605 -0.497
202503 0.550 319.799 0.574
202506 0.568 322.561 0.588
202509 1.182 324.800 1.215
202512 0.829 324.054 0.854
202603 -0.048 330.213 -0.049
202606 1.297 333.952 1.297

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of R$2.01 mean?
Edwards Lifesciences (BSP:E1WL34) has a Cyclically Adjusted FCF per Share of R$2.01 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Edwards Lifesciences and its competitors.
Is Edwards Lifesciences' Cyclically Adjusted FCF per Share too high?
Edwards Lifesciences' current Cyclically Adjusted FCF per Share is R$2.01. Overall, Edwards Lifesciences has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Edwards Lifesciences' Cyclically Adjusted FCF per Share compare to BSX and DXCM?
Edwards Lifesciences' Cyclically Adjusted FCF per Share of R$2.01 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Edwards Lifesciences and its competitors. Edwards Lifesciences's current Cyclically Adjusted FCF per Share is R$2.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edwards Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Edwards Lifesciences (BSP:E1WL34) is currently considered Fairly Valued. The stock's GF Value™ is R$115.66, compared to a current price of R$105.71 — trading 8.6% below its estimated fair value. The current Cyclically Adjusted FCF per Share is R$2.01. Edwards Lifesciences' overall GF Score™ is 93/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Edwards Lifesciences (BSP:E1WL34), the current Cyclically Adjusted FCF per Share is R$2.01 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Edwards Lifesciences (BSP:E1WL34) Overvalued in 2026?

Based on GuruFocus' analysis, Edwards Lifesciences stock appears to be undervalued. The current stock price of R$105.71 is trading 8.6% below its estimated GF Value™ of R$115.66. GuruFocus considers Edwards Lifesciences to be Fairly Valued.

Key valuation signals for BSP:E1WL34:

  • Cyclically Adjusted FCF per Share: R$2.01
  • GF Value™: R$115.66 vs. price of R$105.71 (8.6% below fair value)
  • GF Score™: 93/100 with 5 warning signs

No single metric tells the full story. See the BSP:E1WL34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Edwards Lifesciences Business Description

Address One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
93GF Score

Get the complete analysis for BSP:E1WL34

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$105.71
Price
R$115.66
GF Value